The Effect of IFN- β Treatment on Plasma Levels of BDNF and IL-6 in Relapsing-Remitting Multiple Sclerosis Patients

Conclusion: The IFN- β treatment seems not to be effective for upregulating BDNF and IL-6 in RRMS patients.Neuroimmunomodulation
Source: Neuroimmunomodulation - Category: Allergy & Immunology Source Type: research